Chemoinformaics analysis of Chloranthalactone E
| Molecular Weight | 262.305 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 18 |
| Exact Molecular Weight | 262.121 | nRing | 4 |
| Solubility: LogS | -3.84 | nHRing | 1 |
| Solubility: LogP | 2.117 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 40.2603 |
| nHD | 2 | BPOL | 20.6617 |
| QED | 0.505 |
| Synth | 5.571 |
| Natural Product Likeliness | 2.87 |
| NR-PPAR-gamma | 0.007 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.984 |
| HIA | 0.01 |
| CACO-2 | -4.859 |
| MDCK | 0.0000711 |
| BBB | 0.977 |
| PPB | 0.479461 |
| VDSS | 1.136 |
| FU | 0.667271 |
| CYP1A2-inh | 0.048 |
| CYP1A2-sub | 0.867 |
| CYP2c19-inh | 0.019 |
| CYP2c19-sub | 0.535 |
| CYP2c9-inh | 0.003 |
| CYP2c9-sub | 0.033 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.106 |
| CYP3a4-inh | 0.058 |
| CYP3a4-sub | 0.213 |
| CL | 4.091 |
| T12 | 0.13 |
| hERG | 0.024 |
| Ames | 0.061 |
| ROA | 0.915 |
| SkinSen | 0.185 |
| Carcinogencity | 0.224 |
| EI | 0.013 |
| Respiratory | 0.986 |
| NR-Aromatase | 0.466 |
| Antiviral | Yes |
| Prediction | 0.697956 |